NP35923 Cardiovascular & Respiratory Medicines
Estimated value
—
Awarded value
—
Suppliers
82
Lots
15
Published
25 Jul 2023
Description
This Framework Agreement is for the supply of Cardiovascular & Respiratory Medicines to health boards across NHS Scotland. The Goods were split into eighteen (18) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.
Scope
- Reference
- NP35923
- Commercial tool
- Standalone contract
- Contract dates
This framework includes the option(s) to extend for period(s) up to a total period of twenty-four (24) months upon giving not less than three (3) months written notice of each extension, such notice to expire no later than the date the Framework Agreement is due to expire.
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- Scotland
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Logistics | 5 | quality | — |
| — | 95 | price | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 15 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Lots · 15 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 2 | Epoprostenol powder and solvent (pH12) for solution for infusion vials | £4.4m | cancelled |
| 3 | Epinepherine (Adrenaline) Pre-filled syringes | £1.3m | cancelled |
| 5 | Enoxaparin Sodium Injection | £9.0m | cancelled |
| 7 | Isosorbide Mononitrate Modified Release Capsules and Tablets | £120k | cancelled |
| 8 | Diltiazem Hydrochloride Modified Release Capsules and Tablets | £92k | cancelled |